Scott Gottlieb And The Future Of The FDA
April 25, 2017
Partner Kristi Wolff and associate Donnelly McDowell authored the Law360 article “Scott Gottlieb And The Future Of The FDA.”  The article discusses the hearing held on April 5, 2017 by the Senate Committee on Health, Education, Labor & Pensions in regards to the nomination of Scott Gottlieb, MD, to be the next commissioner of the U.S. Food and Drug Administration.  Gottlieb commented on various FDA policy issues, including drug approvals and pricing, Food Safety Modernization Act implementation, nutrition labeling and antibiotic resisting.

To read the full article, please click here.  Access may require a subscription.